VSG at one year: what TRT actually does to weight loss outcomes

What's this video probably claiming?

At nearly one year post vertical sleeve gastrectomy (VSG), this creator is almost certainly sharing a transformation update, and given the TRT category tag, the implication is that testosterone replacement therapy played some role in the results. That framing is common in bariatric TikTok: post-op patients, particularly men who were obese and likely had secondary hypogonadism from excess adipose tissue, discover their testosterone has normalized or they've started TRT, and they credit it as a co-factor in their recovery, muscle retention, or body recomposition. The video probably weaves together weight loss numbers, before-and-after aesthetics, and a loose claim that TRT was either prescribed post-surgery or accelerated the transformation. Whether that's stated or just implied through hashtag category placement, it's worth unpacking carefully.

What does the science actually show?

The relationship between obesity, VSG, and testosterone is genuinely interesting and frequently misrepresented. Obesity suppresses the hypothalamic-pituitary-gonadal axis. A 2013 study by Pellitero et al. in Obesity Surgery found that testosterone levels in obese men improved significantly after bariatric surgery independent of exogenous hormone use, with total testosterone rising from a mean of roughly 2.4 ng/mL pre-op to over 4.5 ng/mL at 12 months. That's a meaningful biochemical shift driven by fat loss alone. When TRT is added on top of surgical weight loss, the picture gets more complicated. A 2016 Cochrane review by Elraiyah et al. confirmed TRT improves lean mass and reduces fat mass in hypogonadal men, but most trials exclude recent surgical patients, meaning we have limited direct data on TRT as a post-VSG adjunct. Muscle preservation post-bariatric surgery is real, but attributing it primarily to TRT rather than adequate protein intake and resistance training overstates the hormone's independent contribution.

Where does the social media noise diverge from clinical reality?

The biggest distortion you'll find in bariatric-meets-TRT content is the causation problem. A man loses 80 pounds after VSG, his testosterone normalizes, he starts TRT around month four, and by month twelve he looks dramatically different. Social media collapses all of that into "TRT changed everything." What actually happened involves caloric restriction, surgical restriction of intake, metabolic adaptation, improved sleep quality from reduced sleep apnea (itself associated with testosterone improvement per Hoyos et al., 2012, CHEST), and likely a structured gym habit that came with the lifestyle overhaul. TRT may have contributed to lean mass retention, but the Bhasin et al. 2001 NEJM landmark trial showed that testosterone's anabolic effects are dose-dependent and most pronounced at supraphysiologic levels. Replacement-range TRT in a caloric deficit produces modest, not dramatic, body composition changes.

What should you actually know?

If you're post-bariatric surgery and considering TRT, there are real clinical considerations that TikTok transformations skip entirely. VSG significantly alters nutrient absorption timelines, and oral or buccal testosterone formulations may behave differently post-op. Injectable testosterone cypionate or enanthate and transdermal gels bypass GI absorption and are generally preferred for post-bariatric patients, though this is a clinical decision that requires individual evaluation. More importantly, secondary hypogonadism from obesity often resolves with weight loss alone. A study by Alagna et al. in Obesity (2014) found over 60% of men with obesity-related hypogonadism normalized testosterone without exogenous therapy after significant weight loss. Jumping to TRT before confirming persistent hypogonadism post-surgery may be unnecessary and suppresses the body's own recovery of HPG axis function. Lab work, clinical evaluation, and patience matter more than the supplement stack the comments are probably recommending.